Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Is Oncoinvest ASA a Hidden Gem in the Oncology Boom?

LSE:ORU5 - Oncoinvest ASA stock surge March 2026, FTSE biotech rally, UK stock market news, oncology investment stocks, biotech penny stocks UK, high growth pharma stocks, speculative biotech rally, FTSE small cap movers March 2026 are dominating search trends as investors rush to understand …

Ankur Sharma | 23 March 2026

Why Are UK Biotech Stocks Like LSE:AGY Surging in March 2026?

LSE:AGY - Allergy Therapeutics stock price surge today is drawing strong investor attention as FTSE biotech stocks gain momentum in March 2026 amid improving global healthcare sentiment, rising risk appetite, and renewed interest in immunotherapy and allergy vaccine innovation. Investors are actively searching “why …

Ankur Sharma | 23 March 2026

Is This the Right Time to Buy Oxford BioDynamics Stock After 11% Drop?

LSE:OBD - Oxford BioDynamics stock is trending sharply lower today, down around 11% on 20 March 2026, reflecting a combination of company-specific concerns and broader biotech sector weakness. The FTSE AIM-listed precision medicine company is facing intensified selling pressure due to ongoing cash burn, …

Ankur Sharma | 20 March 2026

Is LSE:SBTX the biggest biotech buying opportunity after the crash?

SkinBioTherapeutics Plc (LSE:SBTX) has seen a sharp 35% decline on 20 March 2026, reflecting a combination of company-specific developments and broader biotech market pressures. The sell-off appears to be driven by heightened investor concerns over funding requirements, commercialisation timelines, and potential dilution risks.

Ankur Sharma | 20 March 2026

Can LSE:PXS - Provexis sustain its breakout rally in 2026?

Provexis stock surge March 2026, FTSE AIM healthcare rally, UK small cap breakout stocks, nutrition biotech multibagger potential, Fruitflow global demand growth, cardiovascular health supplements boom — these high-volume SEO keywords are dominating investor searches as Provexis plc jumps over 20% in a single …

Ankur Sharma | 20 March 2026

What Triggered the Rally in LSE:SPI Shares in March 2026?

Key Reasons Behind the SurgeThe primary driver behind the rally isrenewed takeover speculation and strategic interest. Spire has been in ongoing discussions with private equity firms such as Bridgepoint and Triton, with deadlines for potential bids extended into March 2026.Such developments typically support share …

Team Kalkine | 20 March 2026

Smith & Nephew Slips ~5.3% – Is This a Healthcare Buying Opportunity?

The company’s 2026 trading profit guidance of approximately £1.3 billion came in below some market expectations, largely due to two identifiable pressures. The recent acquisition of Integrity Orthopaedics, completed in January 2026, is anticipated to be slightly dilutive to trading profit in the current …

Team Kalkine | 02 March 2026

ConvaTec (LSE:CTEC) Shares Leap 12% on FY25 Beats, Buy Ratings Pile In

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.

Team Kalkine | 24 February 2026

Cizzle Biotechnology (LSE:CIZ) Shares Surge 23% on US Commercial Breakthrough

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research

Team Kalkine | 23 February 2026

AOTI (LSE:AOTI) Shares Down 17% — Is Arizona Medicaid the Key Concern?

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research

Team Kalkine | 23 February 2026
Support

Hi! How can we help you today?

Loading…